Medisplint
Medisplint
Understanding the role of modern biomaterials and structural layouts in achieving long-term implant survival and biological compatibility.
Inlay components are recessed directly into the bony bed of the patella, maintaining a lower patellofemoral profile and minimizing the risk of subluxation. Onlay components resurface the entire prepared patellar surface, maximizing bone coverage and providing an anatomically friendly articulation curve with the femoral trochlear groove.
Fixation stability is achieved via anchoring pegs that project into pre-drilled cancellous channels. A three-peg design distributes rotational torque across a broader area, optimizing stress distribution and cement interlock. Conversely, a single central peg is utilized in smaller patellar profiles or specific anatomic configurations where bony stock is limited.
For cementless applications, patellar metal backings are treated with highly porous titanium plasma spray or trabecular metal structures. These structures simulate natural trabecular bone networks, promoting osteoconduction and establishing secondary biological fixation for lifelong implant performance.
How technological integration, robust raw material supply chains, and automated inspection pipelines define China's leadership in orthopedic contract manufacturing.
Corporate profile, manufacturing capability overview, and global partnership networks.
Medisplint Orthopedic Instruments Co., Ltd. is a professional manufacturer specializing in orthopedic implants, fixation systems, and surgical instruments for trauma, spine, and joint reconstruction. Founded in 2016, the company has developed steadily with a strong focus on innovation, clinical safety, and international expansion. The facility covers approximately 18,500㎡, supporting integrated production, cleanroom assembly, and rigorous quality control operations.
Medisplint reports an annual export revenue of around USD 12 million, with over 7 years of export experience and 10 years of overall industry experience in orthopedic medical device manufacturing. The company operates under strict quality assurance systems including ISO 13485 certification and CE compliance. Quality inspection methods include incoming material inspection, in-process quality control (IPQC), final product inspection (FQC), and third-party laboratory testing. The quality control department consists of 42 dedicated inspectors ensuring product safety, precision, and compliance with international standards.
Step-by-step visual demonstration of raw material preparation, high-speed multi-axis CNC milling, quality verification, and laboratory mechanical testing.
Analyzing standard and specialized workflows where patellar and orthopedic components are deployed clinically.
Modern patient demographics require components that support high degrees of flexion (up to 155°). In Asian regions, cultural habits involving deep squatting and kneeling place higher kinematic demands on patellofemoral tracking. Manufacturers produce specialized asymmetric components that maintain maximum surface contact during deep knee flexion, preventing edge-loading and localized wear.
Revision cases often present significant osteolytic bone loss behind the patellar body. In such scenarios, manufacturers supply high-thickness components or custom porous titanium backings that interlock with trabecular structures, restoring appropriate patellar height and biomechanical balance.
Minimally invasive surgeries (MIS) require specialized surgical instrumentation. Alignment guides and sizing templates are designed to operate within narrow incisions, providing precise osteotomy cuts while sparing surrounding soft tissue and vascular structures.
Ensuring seamless import/export operations, quality certificates, and supply chain alignment with regulatory agencies.
Expert responses to critical engineering, manufacturing, and procurement inquiries.
